Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 3Prostatic Neoplasms 2Neoplasms 2Myofibroma 2Lung Neoplasms 2Breast Neoplasms 2Uterine Neoplasms 1Supratentorial Neoplasms 1Sexual Dysfunction, Physiological 1Scleroderma, Localized 1Rectal Neoplasms 1Pain 1Neurofibromatoses 1Neurodermatitis 1Neuralgia 1Mastodynia 1Lichen Planus 1Leukemia-Lymphoma 1Leiomyoma 1Kidney Neoplasms 1Keratosis, Actinic 1Keratoacanthoma 1Keloid 1Ileus 1Hydrocephalus 1Hordeolum 1Headache 1Granuloma Annulare 1Eyelid Neoplasms 1Epilepsy 1

Interventions

Saline Solution 1Lidocaine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Scleroderma, Localized × Lidocaine × Clear all
NCT03630198 2021-03-11

Pain Outcomes Following Intralesional Corticosteroid Injections

Vanderbilt University Medical Center

Phase 4 Completed
31 enrolled 6 charts

Acne Vulgaris, Alopecia Areata, Dermoid Cyst, Keloid, Keratoacanthoma, Lichen Planus, Neurodermatitis, Scleroderma, Localized, Granuloma Annulare, Cicatrix, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡